Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Evommune (EVMN) EPS (Basic) (2024 - 2025)

Evommune (EVMN) has disclosed EPS (Basic) for 2 consecutive years, with $15.14 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) changed N/A to $15.14 in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.33, a N/A change, with the full-year FY2025 number at -$11.22, up 75.23% from a year prior.
  • EPS (Basic) was $15.14 for Q4 2025 at Evommune, up from -$8.1 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $15.14 in Q4 2025 to a low of -$10.47 in Q3 2024.